GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sesen Bio Inc (STU:PCBK) » Definitions » Additional Paid-In Capital

Sesen Bio (STU:PCBK) Additional Paid-In Capital : €466.97 Mil(As of Dec. 2022)


View and export this data going back to 2016. Start your Free Trial

What is Sesen Bio Additional Paid-In Capital?


Sesen Bio's quarterly additional paid-in capital increased from Jun. 2022 (€464.93 Mil) to Sep. 2022 (€498.57 Mil) but then stayed the same from Sep. 2022 (€498.57 Mil) to Dec. 2022 (€466.97 Mil).

Sesen Bio's annual additional paid-in capital increased from Dec. 2020 (€251.99 Mil) to Dec. 2021 (€431.68 Mil) and increased from Dec. 2021 (€431.68 Mil) to Dec. 2022 (€466.97 Mil).


Sesen Bio Additional Paid-In Capital Historical Data

The historical data trend for Sesen Bio's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sesen Bio Additional Paid-In Capital Chart

Sesen Bio Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 202.31 240.05 251.99 431.68 466.97

Sesen Bio Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 431.68 444.61 464.93 498.57 466.97

Sesen Bio Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Sesen Bio Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Sesen Bio's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Sesen Bio (STU:PCBK) Business Description

Industry
Traded in Other Exchanges
N/A
Address
245 First Street, Suite 1800, Cambridge, MA, USA, 02142
Sesen Bio Inc is a late-stage clinical company advancing targeted fusion protein therapeutics for the treatment of patients with cancer. The company's product candidate, Vicineum, also known as VB4-845, is a locally-administered targeted fusion protein composed of an anti-epithelial cell adhesion molecule antibody fragment tethered to a truncated form of Pseudomonas exotoxin A for the treatment of non-muscle invasive CIS of the bladder in patients previously treated with adequate or less than adequate BCG.

Sesen Bio (STU:PCBK) Headlines

From GuruFocus

Pacific Continental Corp. (PCBK) CEO Hal Brown buys 5,000 Shares

By GuruFocus Research GuruFocus Editor 10-15-2009

Pacific Continental Corp. (PCBK) President/COO Roger S Busse buys 1,000 Shares

By GuruFocus Research GuruFocus Editor 10-15-2009

Pacific Continental Corp. (PCBK) CFO Michael Reynolds sells 1,650 Shares

By GuruFocus Research GuruFocus Editor 02-22-2010